Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
56
CL Quote, Financials, Valuation and Earnings
Last price:
$92.95
Seasonality move
:
0.61%
Day range:
$92.27 - $93.48
52-week range:
$85.32 - $109.30
Dividend yield:
2.17%
P/E ratio:
26.25x
P/S ratio:
3.82x
P/B ratio:
207.49x
Volume:
6.3M
Avg. volume:
5.6M
1-year change:
2.21%
Market cap:
$75.3B
Revenue:
$20.1B
EPS (TTM):
$3.54
Analysts' Opinion
-
Consensus RatingColgate-Palmolive has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 7 Buy ratings, 7 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $98.31, Colgate-Palmolive has an estimated upside of 5.78% from its current price of $92.94.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $84.18 representing 9.43% downside risk from its current price of $92.94.
Fair Value
-
According to the consensus of 15 analysts, Colgate-Palmolive has 5.78% upside to fair value with a price target of $98.31 per share.
CL vs. S&P 500
-
Over the past 5 trading days, Colgate-Palmolive has overperformed the S&P 500 by 0.36% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Colgate-Palmolive does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Colgate-Palmolive revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Colgate-Palmolive reported revenues of $4.9B.
Earnings Growth
-
Colgate-Palmolive has grown year-over-year earnings for 7 quarters straight. In the most recent quarter Colgate-Palmolive reported earnings per share of $0.85.
Enterprise value:
82.8B
EV / Invested capital:
--
Price / LTM sales:
3.82x
EV / EBIT:
19.64x
EV / Revenue:
4.15x
PEG ratio (5yr expected):
2.18x
EV / Free cash flow:
23.90x
Price / Operating cash flow:
21.99x
Enterprise value / EBITDA:
17.18x
Gross Profit (TTM):
$12.1B
Return On Assets:
17.55%
Net Income Margin (TTM):
14.52%
Return On Equity:
450.97%
Return On Invested Capital:
32.03%
Operating Margin:
21.91%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $18.3B | $19.8B | $19.9B | $5.1B | $4.9B | |
| Gross Profit | $10.4B | $11.7B | $12.1B | $3B | $3B | |
| Operating Income | $3.7B | $4.2B | $4.4B | $1B | $1.1B | |
| EBITDA | $3.4B | $4.4B | $4.8B | $1.2B | $1.2B | |
| Diluted EPS | $1.92 | $3.16 | $3.54 | $0.83 | $0.85 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.6B | $5B | $5.5B | $5.6B | $5.8B | |
| Total Assets | $15.8B | $15.7B | $16.2B | $16.6B | $16.6B | |
| Current Liabilities | $4.5B | $4.6B | $4.4B | $5.3B | $6.9B | |
| Total Liabilities | $15.1B | $15B | $15.7B | $16B | $15.9B | |
| Total Equity | $663M | $728M | $425M | $617M | $733M | |
| Total Debt | $7.8B | $7.6B | $8.9B | $8.7B | $8.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.9B | $3.7B | $4B | $681M | $600M | |
| Cash From Investing | -$1.7B | -$671M | -$500M | -$193M | -$159M | |
| Cash From Financing | -$1.1B | -$2.8B | -$3.5B | -$361M | -$458M | |
| Free Cash Flow | $2.2B | $3B | $3.5B | $555M | $476M | |
CL
Sector
Market Cap
$75.3B
$258.9M
Price % of 52-Week High
85.03%
75.55%
Dividend Yield
2.17%
0%
Shareholder Yield
4.2%
2.89%
1-Year Price Total Return
2.21%
-11.52%
Beta (5-Year)
0.394
0.392
Dividend yield:
2.17%
Annualized payout:
$1.98
Payout ratio:
62.17%
Growth streak:
35 years
Technicals
8-day SMA
Buy
Level
$92.07
200-day SMA
Sell
Level
$94.58
Bollinger Bands (100)
Buy
Level
87.88 - 93.06
Chaikin Money Flow
Buy
Level
12.3M
20-day SMA
Buy
Level
$90.88
Relative Strength Index (RSI14)
Buy
Level
56.28
ADX Line
Buy
Level
11.68
Williams %R
Sell
Level
-9.9099
50-day SMA
Buy
Level
$91.89
MACD (12, 26)
Buy
Level
2.10
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Sell
Level
-13.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.2336)
Sell
CA Score
(Annual)
Level (-0.9769)
Buy
Beneish M-Score
(Annual)
Level (-2.8775)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (1.3988)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
Stock Forecast FAQ
In the current month, CL has received 7 Buy ratings 7 Hold ratings, and 1 Sell ratings. The CL average analyst price target in the past 3 months is $98.31.
-
Where Will Colgate-Palmolive Stock Be In 1 Year?
According to analysts, the consensus estimate is that Colgate-Palmolive share price will rise to $98.31 per share over the next 12 months.
-
What Do Analysts Say About Colgate-Palmolive?
Analysts are divided on their view about Colgate-Palmolive share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Colgate-Palmolive is a Sell and believe this share price will drop from its current level to $84.18.
-
What Is Colgate-Palmolive's Price Target?
The price target for Colgate-Palmolive over the next 1-year time period is forecast to be $98.31 according to 15 Wall Street analysts, 7 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is CL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Colgate-Palmolive is a Leans Bullish. 7 of 15 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of CL?
You can purchase shares of Colgate-Palmolive via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Colgate-Palmolive shares.
-
What Is The Colgate-Palmolive Share Price Today?
Colgate-Palmolive was last trading at $92.95 per share. This represents the most recent stock quote for Colgate-Palmolive. Yesterday, Colgate-Palmolive closed at $92.94 per share.
-
How To Buy Colgate-Palmolive Stock Online?
In order to purchase Colgate-Palmolive stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
